Renovate Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 4.00 M
- Revenue Growth 4007.37%
- Profit Growth 20.46%
- Ebitda 20.99%
- Net Worth -50.12%
- Total Assets 36.63%
About Renovate Biologicals
Renovate Biologicals Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 July 2015 (Nine years and six months 28 days old ). Its registered office is in Mahabub Nagar, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Munagapati Kumar, Kota Vijaykumar, Mudunuru Rao, and One other member serve as directors at the Company.
Company Details
-
Location
Mahabub Nagar, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24100TG2015PTC099749
-
Company No.
099749
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Jul 2015
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Renovate Biologicals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munagapati Kumar
|
Director | 09-Jul-2015 | Current |
|
Kota Vijaykumar
|
Director | 13-Jul-2018 | Current |
|
Mudunuru Rao
|
Director | 01-Nov-2019 | Current |
|
Devesh Kedia
|
Director | 14-Dec-2019 | Current |
Financial Performance of Renovate Biologicals.
Renovate Biologicals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 4007.37% increase. The company also saw a substantial improvement in profitability, with a 20.46% increase in profit. The company's net worth observed a substantial decline by a decrease of 50.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renovate Biologicals?
In 2021, Renovate Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹4.00 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2018 | Bank Of India | ₹4.00 M | Satisfied |
How Many Employees Work at Renovate Biologicals?
Renovate Biologicals has a workforce of 18 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renovate Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renovate Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
